Elder Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cutting Edge Information
Lifecycle management planning begins during phase I drug trials for 43% of management teams
October 26th, 2005
Survey data from Cutting Edge Information's new report, "Defending Brand Revenue: Pharmaceutical Lifecycle Management Planning," reveals that 43% of global lifecycle management (LCM) teams begin LCM planning for a brand during phase I development. One interviewed executive claims the decisions made during this early planning period are as equally important as those made during a drug's final year of market exclusivity. Early stage lifecycle management planning typically involves determining a compound's proclivity for multiple formulations, multiple indications and whether it can react well in combination with other compounds. Some companies even...
Source: Elder Law Weekly (2005-10-26)
|
